In the value-based care debate, an essential question is: How is value being defined?
Is value defined by lowering the cost of care or the quality of treatment outcomes? Ultimately, achieving and sustaining high-value, cost-effective care for patients is the goal of any healthcare system. But calculating the value of treatment can be a challenge.
Value calculators have emerged from this debate about the rising cost of care. These tools attempt to provide a means for quantifying cost and comparative effectiveness. However, these tools mostly rely on randomized clinical trial data for assessing clinical benefit, instead of real-world evidence and patient-reported outcomes, and base their analysis on drug use as opposed to a more holistic view of oncology care.
In this article, experts from Cardinal Health Specialty Solutions, review the limitations and advantages of several value calculators and suggest opportunities for refinement.